MF59-eH1N1_f

BIOLOGICAL3 trials

Sponsors

Novartis, Novartis Vaccines

Conditions

InfluenzaNovel 2009 Influenza H1N1

Phase 2

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults

CompletedNCT00973349

NovartisInfluenza

Start: 2009-09-30End: 2010-12-31Updated: 2015-12-07

Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months

CompletedNCT00996307

Novartis VaccinesInfluenza

Start: 2009-10-31End: 2010-12-31Updated: 2017-05-30

Phase 3

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)

CompletedNCT00973700

Novartis VaccinesNovel 2009 Influenza H1N1

Start: 2009-08-31End: 2010-10-31Updated: 2015-12-02